Riskpilot← Back to searchSign inGet full accessArjova Oy
OYDissolvedY-tunnus 2409269-1Lepolantie 101-BMedical specialists activities · NACE 8622Est. 20111 employees
Revenue 2025
EUR 484K
-14% vs 2024
EBITDA margin
74.0%
-1% vs 2024
Equity ratio
83.3%
Financial strength
Net profit 2025
EUR 267K
-6% vs 2024
| Revenue | EUR 484K | -14% |
| EBITDA | EUR 358K | -1% |
| Net profit | EUR 267K | -6% |
| Total assets | EUR 2M | +16% |
| Equity | EUR 1,6M | +1% |
| Employees | 1 | — |
Legal name
Arjova Oy
Y-tunnus number
2409269-1
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
18. toukokuuta 2011
Share capital
EUR 2 500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on terveys- ja sosiaalipalvelut, muu rahoitusta palveleva toiminta (pl. vakuutus- ja eläkevakuutustoiminta).
Address
Lepolantie 101-B
Phone
+3580503410683
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 303 | 336 | 449 | 560 | 484 |
| Staff expenses | −8 | −5 | −4 | −10 | −8 |
| EBITDA | 225 | 255 | 339 | 361 | 358 |
| Depreciation & amort. | −1 | −1 | −2 | −6 | −14 |
| EBIT | 225 | 254 | 338 | 355 | 344 |
| Net financials | −1 | −2 | 1 | 1 | −10 |
| Profit before tax | 224 | 252 | 339 | 356 | 334 |
| Tax | 45 | 50 | 68 | 71 | 67 |
| Net profit | 179 | 201 | 271 | 285 | 267 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 353 | 1 425 | 1 559 | 1 706 | 1 979 |
| Equity | 1 059 | 1 261 | 1 471 | 1 638 | 1 649 |
| Long-term debt | 142 | 64 | 4 | 2 | 183 |
| Short-term debt | 152 | 101 | 84 | 66 | 147 |
| Total debt | 294 | 165 | 88 | 68 | 330 |
EBITDA margin
74.0%
This company
15.8%
Market median
+368% vs market
20212025
Equity ratio
83.3%
This company
38.2%
Market median
+118% vs market
20212025
Return on equity
16.2%
This company
18.4%
Market median
+12% vs market
20212025
Net profit margin
55.2%
This company
8.1%
Market median
+581% vs market
20212025
Asset turnover
0.24×
This company
1.12×
Market median
-79% vs market
20212025
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
TM Audit | Audit | 2018 |
AJ Chief Executive Officer | Chief Executive Officer | 2011 |
PJ Deputy auditor | Deputy auditor | 2018 |
ML Deputy Member | Deputy Member | 2013 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2013 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Arjova Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Timo Matti Kervinen | Audit | 0 companies |
| Arttu Johannes Vaalas | Chief Executive Officer | 0 companies |
| Perttu Johannes Mettomäki | Deputy auditor | 0 companies |
| Mirja Lea Susanna Ahonen | Deputy Member | 0 companies |
| Jenni Kaarina Vaalas | Board of Directors | 0 companies |